TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
2,245,303
|
1,792,626
|
2,042,515 |
| Earnings before taxes |
-254,602
|
-439,990
|
-136,555 |
| Total assets |
3,460,247
|
3,733,699
|
4,090,943 |
| Current assets |
1,070,897
|
1,309,824
|
1,706,844 |
| Current liabilities |
1,095,429
|
908,545
|
691,308 |
| Equity capital |
1,750,675
|
2,082,735
|
2,621,030 |
| - share capital |
201,000
|
201,000
|
201,000 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
50.6%
|
55.8%
|
64.1% |
| Turnover per employee |
6,415
|
5,122
|
5,836 |
| Profit as a percentage of turnover |
-11.3%
|
-24.5%
|
-6.7% |
| Return on assets (ROA) | |||
| Current ratio |
97.8%
|
144.2%
|
246.9% |
| Return on equity (ROE) |
-14.5%
|
-21.1%
|
-5.2% |
| Change turnover |
452,677
|
-249,889
|
-303,781 |
| Change turnover % |
25%
|
-12%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.